Therapies for pediatric seborrheic dermatitis

Pediatric Annals

Volumn 38, Issue 6, 2009, Pages 333-338

  Poindexter, Gabriele B ^a   Burkhart, Craig N ^a   Morrell, Dean S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM LACTATE; ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; BETAMETHASONE; CALCINEURIN INHIBITOR; CICLOPIROXOLAMINE; CORTICOSTEROID; EXINA; FLUCONAZOLE; FLUTRIMAZOLE; ITRACONAZOLE; KERATOLYTIC AGENT; KETOCONAZOLE; PIMECROLIMUS; PLACEBO; PLEXION; PRAMICONAZOLE; PYRROLE DERIVATIVE; ROSAC; ROSULA; SALICYLIC ACID; SEBCLAIR; SELENIUM SULFIDE; SULFACETAMIDE; TACROLIMUS; TAR; TEA TREE OIL; UNCLASSIFIED DRUG; UREA; XOLEGEL; COSMETIC; EMOLLIENT AGENT;

CHILDHOOD DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; GROUPS BY AGE; HUMAN; NONHUMAN; PEDIATRICS; REVIEW; SCALP; SEBORRHEIC DERMATITIS; ADOLESCENT; ADULT; CHILD; DRUG COMBINATION; INTRADERMAL DRUG ADMINISTRATION; SKIN DISEASE; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; CHILD; DERMATITIS, SEBORRHEIC; DRUG THERAPY, COMBINATION; EMOLLIENTS; HAIR PREPARATIONS; HUMANS; KERATOLYTIC AGENTS; KETOCONAZOLE; SCALP DERMATOSES; TREATMENT OUTCOME;

EID: 67849086650     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/00904481-20090521-01     Document Type: Review

References (39)

1. Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ. Fitzpatrick's Dermatology in General Medicine. 7th ed. New York: McGraw-Hill Companies, Inc.;2008:219-225.
2. Schwartz RA, Janusz CA, Janniger CK. Seborrheic dermatitis: an overview. Am Fam Physician. 2006;74(1):125-130.
3. Foley P, Zuo Y, Plunkett A, Merlin K, Marks R. The frequency of common skin conditions in preschool-aged children in Australia: seborrheic dermatitis and pityriasis capitis (cradle cap). Arch Dermatol. 2003;139(3):318-322. (Pubitemid 36335764)
4. Tamer E, Ilhan MN, Polat M, Lenk N, Alli N. Prevalence of skin diseases among pediatric patients in Turkey. J Dermatol. 2008;35(7):413-418. (Pubitemid 351977688)
5. Wananukul S, Chindamporn A, Yumyourn P, Payungporn S, Samathi C, Poovorawan Y. Malassezia furfur in infantile seborrheic dermatitis. Asian Pac J Allergy Immunol. 2005;23(2-3):101-105. (Pubitemid 41535684)
6. Dawson TL Jr. Malassezia globosa and restricta: breakthrough understanding of the etiology and treatment of dandruff and seborrheic dermatitis through whole-genome analysis. J Investig Dermatol Symp Proc. 2007;12(2):15-19.
7. Scheinfeld N. Diaper dermatitis: a review and brief survey of eruptions of the diaper area. Am J Clin Dermatol. 2005;6(5):273-281. (Pubitemid 41577402)
8. O'Connor NR, McLaughlin MR, Ham P. Newborn skin: Part I. Common rashes. Am Fam Physician. 2008;77(1):47-52.
9. Williams JV, Eichenfield LF, Burke BL, Barnes-Eley M, Friedlander SF. Prevalence of scalp scaling in prepubertal children. Pediatrics. 2005;115(1):e1-6.
10. Al-Dhalimi MA. Neonatal and infantile erythroderma: a clinical and followup study of 42 cases. J Dermatol. 2007 May;34(5):302-307.
11. Evans DI, Holzel A, MacFarlane H. Yeast opsonization defect and immunoglobulin deficiency in severe infantile dermatitis (Leiner's disease). Arch Dis Child. 1977;52(9):691-695. (Pubitemid 8190955)
12. Sonea MJ, Moroz BE, Reece ER. Leiner's disease associated with diminished third component of complement. Pediatr Dermatol. 1987;4(2):105-107.
13. Grimalt R. A practical guide to scalp disorders. J Investig Dermatol Symp Proc. 2007;12(2):10-14.
14. Gupta AK, Nicol K. The use of sulfur in dermatology. J Drugs Dermatol. 2004;3(4):427-431.
15. Fleischer AB Jr. Diagnosis and management of common dermatoses in children: atopic, seborrheic, and contact dermatitis. Clin Pediatr (Phila). 2008;47(4):332-346.
16. Faergemann J. Management of seborrheic dermatitis and pityriasis versicolor. Am J Clin Dermatol. 2000;1(2):75-80.
17. Geria AN, Scheinfeld NS. Pramiconazole, a triazole compound for the treatment of fungal infections. IDrugs. 2008;11(9):661-670.
18. Piérard GE, Ausma J, Henry F, Vroome V, et al. A pilot study on seborrheic dermatitis using pramiconazole as a potent oral anti-Malassezia agent. Dermatology. 2007;214(2):162-169. (Pubitemid 46377243)
19. Shemer A, Kaplan B, Nathansohn N, Grunwald MH, Amichai B, Trau H. Treatment of moderate to severe facial seborrheic dermatitis with itraconazole: an open noncomparative study. Isr Med Assoc J. 2008 Jun;10(6):417-418.
20. Noguera J, Lerís E, Algueró M, Boncompte E, Izquierdo I; Grupo de trabajo flutrimazol gel. [Review of the clinical efficacy of flutrimazole gel in the treatment of dandruff and/or seborrheic dermatitis.] [Article in Spanish] Rev Iberoam Micol. 1998;15(1):28-32.
21. Cömert A, Bekiroglu N, Gürbüz O, Ergun T. Efficacy of oral fluconazole in the treatment of seborrheic dermatitis: a placebocontrolled study. Am J Clin Dermatol. 2007;8(4):235-238. (Pubitemid 47195667)
22. Ratnavel RC, Squire RA, Boorman GC. Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis. J Dermatolog Treat. 2007;18(2):88-96.
23. Peter RU, Richarz-Barthauer U. Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial. Br J Dermatol. Mar;132(3):441-445.
24. Faergemann J, Borgers M, Degreef H. A new ketoconazole topical gel formulation in seborrhoeic dermatitis: an updated review of the mechanism. Expert Opin Pharmacother. 2007;8(9):1365-1371. (Pubitemid 47034422)
25. Scheinfeld N. Ketoconazole: a review of a workhorse antifungal molecule with a focus on new foam and gel formulations. Drugs Today (Barc). 2008;44(5):369-380.
26. Elewski B, Ling MR, Phillips TJ. Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase III trial. J Drugs Dermatol. 2006;5(7):646-650.
27. Elewski BE, Abramovits W, Kempers S, et al. A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions. J Drugs Dermatol. 2007;6(10):1001-1008.
28. Swinyer LJ, Decroix J, Langner A, Quiring JN, Blockhuys S. Ketoconazole gel 2% in the treatment of moderate to severe seborrheic dermatitis. Cutis. 2007;79(6):475-482.
29. Warshaw EM, Wohlhuter RJ, Liu A, et al. Results of a randomized, double-blind, vehicle- controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis. J Am Acad Dermatol. 2007;57(2):257-264. (Pubitemid 47048856)
30. Rigopoulos D, Ioannides D, Kalogeromitros D, Gregoriou S, Katsambas A. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial. Br J Dermatol. 2004;151(5):1071-1075. (Pubitemid 39573897)
31. Braza TJ, DiCarlo JB, Soon SL, McCall CO. Tacrolimus 0.1% ointment for seborrhoeic dermatitis: an open-label pilot study. Br J Dermatol. 2003;148(6):1242-1244. (Pubitemid 36819226)
32. Meshkinpour A, Sun J, Weinstein G. An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis. J Am Acad Dermatol. 2003;49(1):145-147. (Pubitemid 36801654)
33. Munzenberger PJ, Montejo JM. Safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Pharmacotherapy. 2007;27(7):1020-1028. (Pubitemid 46986689)
34. Veraldi S, Menter A, Innocenti M. Treatment of mild to moderate seborrhoeic dermatitis with MAS064D (Sebclair), a novel topical medical device: results of a pilot, randomized, double-blind, controlled trial. J Eur Acad Dermatol Venereol. 2008;22(3):290-296. (Pubitemid 351255418)
35. Satchell AC, Saurajen A, Bell C, Barnetson RS. Treatment of dandruff with 5% tea tree oil shampoo. J Am Acad Dermatol. 2002;47(6):852-855. (Pubitemid 35403042)
36. Brodell RT, Patel S, Venglarcik JS, Moses D, Gemmel D. The safety of ketoconazole shampoo for infantile seborrheic dermatitis. Pediatr Dermatol. 1998;15(5):406-407. (Pubitemid 28465818)
37. Wannanukul S, Chiabunkana J. Comparative study of 2% ketoconazole cream and 1% hydrocortisone cream in the treatment of infantile seborrheic dermatitis. J Med Assoc Thai. 2004;87 Suppl 2:S68-S71. (Pubitemid 41032722)
38. Danby FW, Maddin WS, Margesson LJ, Rosenthal D. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol. 1993;29(6):1008-1012. (Pubitemid 23360336)
39. Reygagne P, Poncet M, Sidou F, Soto P. Clobetasol propionate shampoo 0.05% in the treatment of seborrheic dermatitis of the scalp: results of a pilot study. Cutis. 2007;79(5):397-403.